Vaccine Therapy for Newly Diagnosed Glioblastoma Multiforme

The purpose of this research study is to determine if an investigational dendritic cell vaccine, called pp65 DC, is effective for the treatment of a specific type of brain tumor called glioblastoma (GBM) when given with stronger doses of routine chemotherapy.

August 09, 2017